Deerfield.Com (Singulargenomics.Com)
bd_82681111eb8a4979 · schema v1 · pii pii-v1
Full breach record for Deerfield.Com (Singulargenomics.Com) →2 incidents on fileThreat-actor claim — not a regulatory filing
This row is a claim by the ransomware group INC Ransom on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
Singular Genomics https://www.singulargenomics.com/ The company, known for its next-generation sequencing technologies such as the G4® Sequencing Platform and the upcoming G4XTM Spatial Sequencer, is now focused on further innovation in genomic and spatial multiomics research. Singular Genomics Systems, Inc. is a life science technology company founded in 2016 that develops next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians in advancing science and medicine. The company's mission centers on leveraging its proprietary Sequencing Engine platform, which underpins its core product tenets of accuracy, speed, flexibility, and scale. Its commercially available G4 Sequencing Platform is a benchtop genomic sequencer designed for fast and accurate results, while the G4X Spatial Sequencer, an upgrade to the G4 platform, enables high-throughput in situ direct sequencing of RNA, targeted transcriptomics, and proteomics profiling from formalin-fixed, paraffin-embedded (FFPE) tissues. The company is also developing the PX Integrated Solution, a multiomics platform that combines single-cell analysis, spatial analysis, genomics, and proteomics in one instrument. As of February 21, 2025, Singular Genomics was taken private following the closing of an acquisition by Deerfield Management. The company is headquartered in San Diego, California, with additional operations in La Jolla. Target CEO: Drew Spaventa https://www.linkedin.com/in/drew-spaventa-98087213/ Josh Stahl https://www.linkedin.com/in/joshua-stahl-77238627/ Target Owner: James E. Flynn https://www.linkedin.com/in/james-flynn-99304a72/ Deerfield Management Company, L.P. Singular Genomics is currently owned by Deerfield Management Company, L.P., following the completion of its acquisition on February 21, 2025. The transaction involved an affili
J jump to incidentP pin to compareR raw source
Incident timeline — mostly unverified
? — ?
Breach window unknown
Dec 18, 2025
Claim posted
—
No filing yet · watching
Compliance clocks stay unassessable until a regulatory filing lands. Dashed segments fill in automatically when corroboration arrives.
Claim → filing
—
Compliance clock
Not assessable
Evidence ladder
Attacker assertion only. Establishes: claim date, group, alleged victim.
Unlocks: incident narrative, operational impact. Still no compliance clock.
Unlocks: discovery date, data types, affected count, compliance clock.
Unlocks: materiality, stated response, full audit trail. Ceiling removed.
No regulatory filing corroborates this yet — it is the attacker's own assertion. Watch this entity to be notified the moment a filing corroborates or contradicts it.
Source ceiling
- actor name
- victim claim
- ransom/leak status
- discovery date
- materiality
- notification
- affected count
- confirmed data types
- compliance clock
The ✕ fields stay blank until a regulatory filing or victim disclosure lands.